Effects of PG2 on Fatigue-Related Symptom Clusters
Status:
Completed
Trial end date:
2017-05-08
Target enrollment:
Participant gender:
Summary
This study is for an "add-on" study to the "main" study (Protocol No.: PH-CP012). The
information of patients from main study will be collected by questionnaire survey and
actigraphy measurement to evaluate the relationship between fatigue, depression and sleep
disorder and the efficacy of PG2 after treatment.The association between symptom cluster and
circadian rhythm will be also further explored.